Renaissance Technologies’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,000
| Closed | -$381K | – | 3874 |
|
|
2020
Q4 | $381K | Sell |
26,000
-162,257
| -86% | -$2.38M | ﹤0.01% | 2940 |
|
|
2020
Q3 | $2.67M | Sell |
188,257
-167,064
| -47% | -$2.37M | ﹤0.01% | 1949 |
|
|
2020
Q2 | $2.87M | Buy |
+355,321
| New | +$2.87M | ﹤0.01% | 1969 |
|
|
2018
Q4 | – | Sell |
-116,100
| Closed | -$673K | – | 3718 |
|
|
2018
Q3 | $673K | Sell |
116,100
-27,900
| -19% | -$162K | ﹤0.01% | 2756 |
|
|
2018
Q2 | $864K | Buy |
144,000
+102,300
| +245% | +$614K | ﹤0.01% | 2656 |
|
|
2018
Q1 | $300K | Sell |
41,700
-115,322
| -73% | -$830K | ﹤0.01% | 3080 |
|
|
2017
Q4 | $1.14M | Buy |
+157,022
| New | +$1.14M | ﹤0.01% | 2613 |
|
|
2016
Q2 | – | Sell |
-25,478
| Closed | -$236K | – | 3578 |
|
|
2016
Q1 | $236K | Buy |
25,478
+1,380
| +6% | +$12.8K | ﹤0.01% | 3045 |
|
|
2015
Q4 | $304K | Buy |
+24,098
| New | +$304K | ﹤0.01% | 2882 |
|